Analysis of Gut Microbiota in Patients with Parkinson’s Disease

Gut microbiota of patients with Parkinson’s disease and healthy volunteers was analyzed by the method of high throughput 16S rRNA sequencing of bacterial genomes. In patients with Parkinson’s diseases, changes in the content of 9 genera and 15 species of microorganisms were revealed: reduced content of Dorea, Bacteroides, Prevotella, Faecalibacterium, Bacteroides massiliensis, Stoquefichus massiliensis, Bacteroides coprocola, Blautia glucerasea, Dorea longicatena, Bacteroides dorei, Bacteroides plebeus, Prevotella copri, Coprococcus eutactus, and Ruminococcus callidus, and increased content of Christensenella, Catabacter, Lactobacillus, Oscillospira, Bifidobacterium, Christensenella minuta, Catabacter hongkongensis, Lactobacillus mucosae, Ruminococcus bromii, and Papillibacter cinnamivorans. This microbiological pattern of gut microflora can trigger local inflammation followed by aggregation of α-synuclein and generation of Lewy bodies.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Akbar U, He Y, Dai Y, Hack N, Malaty I, McFarland NR, Hess C, Schmidt P, Wu S, Okun MS. Weight loss and impact on quality of life in Parkinson’s disease. PLoS One. 2015;10(5):e0124541.

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods. 2010;7(5):335-336.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Côté M, Bourque M, Poirier AA, Aubé B, Morissette M, Di Paolo T, Soulet D. GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson’s disease. Neurobiol. Dis. 2015;82:99-113.

    Article  PubMed  Google Scholar 

  4. 4.

    Egshatyan L, Kashtanova D, Popenko A, Tkacheva O, Tyakht A, Alexeev D, Karamnova N, Kostryukova E, Babenko V, Vakhitova M, Boytsov S. Gut microbiota and diet in patients with different glucose tolerance. Endocr. Connect. 2016;5(1):1-9.

    CAS  PubMed  Google Scholar 

  5. 5.

    Ghaisas S, Maher J, Kanthasamy A. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol. Ther. 2016;158:52-62.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT, Spector TD, Clark AG, Ley RE. Human genetics shape the gut microbiome. Cell. 2014;159(4):789-799.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Hanski I, von Hertzen L, Fyhrquist N, Koskinen K, Torppa K, Laatikainen T, Karisola P, Auvinen P, Paulin L, Mäkelä MJ, Vartiainen E, Kosunen TU, Alenius H, Haahtela T. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc. Natl Acad. Sci. USA. 2012;109(21):8334-8339.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM. Colonic bacterial composition in Parkinson’s disease. Mov. Disord. 2015;30(10):1351-1360.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Lapthorne S, Pereira-Fantini PM, Fouhy F, Wilson G, Thomas SL, Dellios NL, Scurr M, O’Sullivan O, Ross RP, Stanton C, Fitzgerald GF, Cotter PD, Bines JE. Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome. Gut Microbes. 2013;4(3):212-221.

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Levy M, Thaiss CA, Elinav E. Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome. Genome Med. 2015;7(1):120. doi: 10.1186/s13073-015-0249-9.

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014;30(21):3123-3124.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Ritari J, Salojärvi J, Lahti L, de Vos WM. Improved taxonomic assignment of human intestinal 16S rRNA sequences by adedicated reference database. BMC Genomics. 2015;16. ID 1056. doi: 10.1186/s12864-015-2265-y.

    Article  Google Scholar 

  13. 13.

    Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov. Disord. 2015;30(3):350-358.

    Article  PubMed  Google Scholar 

  14. 14.

    Vizcarra JA, Wilson-Perez HE, Espay AJ. The power in numbers: gut microbiota in Parkinson’s disease. Mov. Disord. 2015;30(3):296-298.

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to V. A. Petrov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 162, No. 12, pp. 700-703, December, 2016

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Petrov, V.A., Saltykova, I.V., Zhukova, I.A. et al. Analysis of Gut Microbiota in Patients with Parkinson’s Disease. Bull Exp Biol Med 162, 734–737 (2017). https://doi.org/10.1007/s10517-017-3700-7

Download citation

Key Words

  • gut microbiota
  • Parkinson’s disease
  • 16S rRNA sequencing